Trials / Completed
CompletedNCT05314218
The Objective of This Multicentre Study is to Collect Operative Data on the Related Clinical Functional Outcomes and Complications and of Market Approved Alcis Electrophysiology Catheters to Demonstrate Safety and Performance of These Devices in a Real-world Setting
EPICADIA - Electrophysiologic Performance Investigation for CArdiac DIAgnosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 168 (actual)
- Sponsor
- Alcis · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this multicentre study is to collect operative data on the related clinical functional outcomes and complications and of market approved Alcis electrophysiology catheters to demonstrate safety and performance of these devices in a real-world setting.
Detailed description
Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Alcis devices and support peer-reviewed publications on products performance and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Electrophysiology catheters and cables | The Xtrem electrophysiology catheter was developed for diagnosis of cardiac arrhythmias. Their function is to collect by contact, electrical signals generated by the heart muscle. Xtrem are inserted via femoral vena cava or via artery and can be used in two occasions: * Exploration procedures for diagnosis alone * Diagnosis before ablation procedure An extension cable is used to connect the catheter to a stimulation/ recording device. |
Timeline
- Start date
- 2022-05-23
- Primary completion
- 2023-05-25
- Completion
- 2023-05-26
- First posted
- 2022-04-06
- Last updated
- 2023-06-13
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05314218. Inclusion in this directory is not an endorsement.